When GLP-1 binds to receptors in these areas, it activates anorexigenic (appetite-suppressing) neurons whilst inhibiting orexigenic (appetite-stimulating) pathways, contributing to reduced food intake and increased satiety
Instead, it works gradually, with noticeable changes typically appearing within 4 to 6 weeks
Park JS, Kwon J, Choi HJ, Lee C
Wegovy is the one indicated for obesity treatment in people without diabetes
This central mechanism is distinct from PDE5 inhibitors like sildenafil, which act peripherally on vascular smooth muscle
The Bad days always came 2 days after injecting. Speak UpEven If Its Awkward Many patients stay silent, fearing doctors will take them off the meds